Dana le
Optometrist · Long Beach, CANPI 1285030015
Payments from drug & device makers
Across 104 payments — averaging $28.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$909
- Alcon$771
- Aerie Pharmaceuticals, Inc.$354
- Bausch & Lomb Americas Inc.$161
- Glaukos Corporation$121
- Tarsus Pharmaceuticals, Inc.$90
- plus $564 from 11 others
What the payments were for
- Food & beverage$2,969100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 31 | $909 |
| Alcon | 37 | $771 |
| Aerie Pharmaceuticals, Inc. | 8 | $354 |
| Bausch & Lomb Americas Inc. | 4 | $161 |
| Glaukos Corporation | 1 | $121 |
| Tarsus Pharmaceuticals, Inc. | 3 | $90 |
| Sun Pharmaceutical Industries Inc. | 3 | $87 |
| Johnson & Johnson Vision Care, Inc. | 3 | $85 |
| Oyster Point Pharma, Inc. | 3 | $82 |
| Astellas Pharma Global Development | 1 | $76 |
| Dompe US, Inc. | 3 | $64 |
| Shire North American Group Inc | 2 | $48 |
| Coopervision Inc. | 1 | $44 |
| Thea Pharma Inc. | 1 | $24 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $23 |
| Sight Sciences, Inc. | 1 | $17 |
| Amgen | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Rhopressa$236
- Rocklatan$236
- VUITY$125
- LUMIGAN$124
- COMBIGAN$124
- Precision 1$122
- KXL System$121
- Photrexa$121
- RESTASIS$113
How this compares
$2,969 in reported general payments places this provider in the 85th percentile of 6,778 optometrist providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XiidraLifitegrast | 135 | $222,297 |
| LumiganBimatoprost | 226 | $113,235 |
| RestasisCyclosporine | 50 | $62,889 |
| RocklatanNetarsudil Mesylat/Latanoprost | 144 | $59,555 |
| Cyclosporine | 30 | $21,208 |
| Brimonidine Tartrate | 154 | $19,174 |
| CombiganBrimonidine Tartrate/Timolol | 38 | $17,025 |
| Alphagan PBrimonidine Tartrate | 36 | $16,775 |
| RhopressaNetarsudil Mesylate | 35 | $12,314 |
| Latanoprost | 737 | $10,135 |
| Restasis MultidoseCyclosporine | 15 | $9,731 |
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 58 | $9,417 |
| SimbrinzaBrinzolamide/Brimonidine Tart | 27 | $7,724 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 441 | $7,179 |
| Travoprost | 43 | $3,905 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Bausch & Lomb Americas Inc.Xiidra | $161 | $222,297135 claims |
| AbbVieLumigan, Restasis, Combigan, Alphagan P, Restasis Multidose | $909 | $219,655365 claims |
| Aerie Pharmaceuticals, Inc.Rocklatan, Rhopressa | $354 | $71,869179 claims |
| AlconSimbrinza | $771 | $7,72427 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 6,778 optometrist providers in California.
Other optometrist in Long Beach
- Ashley OwyangLong Beach$117K
- Meng LinBerkeley$6.9M
- Steve YoelinNewport Beach$6.1M
- Matthew GellerSpring Valley$3.5M
- David Kasanoffla Mesa$1M
- Colton HeinrichFullerton$987K
- Elsa PaoOakland$910K
- Keith WanSan Diego$887K
- Selena ChanSan Francisco$677K
- Melissa EricksonDavis$522K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.